Keywords: Sphingolipid domains; H-bonding network; Eukaryotic plasma membrane; Membrane dipole potential; Lipid phase behavior; Cholesterol; 2-OH-FA; 2-hydroxy-fatty acids; 2-OH-OA; 2-hydroxyoleic acid; AFM; atomic force microscopy; CERK; ceramide kinase; CerS; cer
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α-GlcChol; 1-O-cholesteryl-α-d-glucopyranoside; α-Syn; α-synuclein; β-GlcChol; 1-Î-cholesteryl-β-d-glucopyranoside or β-cholesterylglucoside; BMP; bis (monoacylglycero) phosphate; CERT; ceramide transfer protein; CNS; central nervous system; ER; e
Keywords: AAV; adeno-associated virus; CNS; central nervous system; DLB; dementia with Lewy bodies; ERAD; endoplasmic reticulum associated-degradation; ERT; enzyme replacement therapy; FDA; Food and Drug Administration; GBA1; lysosomal glucocerebrosidase gene; GBA2
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia
Keywords: AD; autosomal dominant; AOA1; ataxia with oculomotor apraxia type 1; AR; autosomal recessive; ARCA; autosomal recessive cerebellar ataxia; ATM; ataxia talengiectasia; FA; Friedreich ataxia; GBA2; b-glucosidase 2; HSPs; hereditary spastic paraplegias; NGS;
N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV
Keywords: NB-DNJ; N-butyldeoxynojirimycin; GCS; glucosylceramide synthase; GSL; glycosphingolipid; CMH; ceramide monohexoside; CDH; ceramide dihexoside; GBA2; glucocerebrosidase; NPC; Niemann-Pick type C; SRT; substrate reduction therapy; Mucolipidosis type IV; Mig
Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia/cerebellar ataxia (SPG46)
Keywords: Glucosylceramide; Spastic paraplegia; Cerebellar ataxia; Miglustat; GBA2; Enzyme activity; SPG46; Cer; ceramide; GBA; glucocerebrosidase; GBA2; β-glucosidase 2; Glc; glucose; GlcCer; glucosylceramide; NB-DGJ; N-butyldeoxygalactonojirimycin; NB-DNJ; N-but
Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease
Keywords: BBB; blood-brain barrier; CBE; conduritol β-epoxide; Cer; ceramide; D-MEM; Dulbeco Eagle's minimal essential medium; ERT; enzyme replacement therapy; GBA1; lysosomal glucocerebrosidase; GBA2; non-lysosomal glucocerebrosidase; GlcCer; glucosylceramide;
Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1
Keywords: β-ChlGlc; cholesteryl glucoside; GBA1; β-glucosidase 1, lysosomal acid β-glucocerebrosidase; GBA2; β-glucosidase 2, non-lysosomal β-glucocerebrosidase; GBA3; cytosolic glucocerebrosidase; GCase; glucocerebrosidase; GlcCer; glucosylceramide; LPH; lact
Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans
Keywords: BG; bile acid-3-O-β-glucoside; GBA1; β-glucosidase 1, lysosomal-glucocerebrosidase; GBA2; β-glucosidase 2, non-lysosomal glucocerebrosidase; LABG; lithocholic acid-3-O-β-glucoside; β-Glucosidase 1; (GBA1); β-Glucosidase 2 (GBA2); Bile acid β-glucos